论文信息 - Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma. - 字舞流文

Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma.

L. Qin | C. Antonescu | S. Singer | G. Schwartz | W. Tap | M. Gounder | A. Crago | M. Dickson | M. Keohan | Jonathan Landa | S. D’Angelo | M. Condy | Yelena Ustoyev | Dustin D. Rathbone